Skip to main content

The rockefeller university

News & HighlightsNews
Displaying 164 of 2907 articles.
Michel C. Nussenzweig honored with the 2016 Robert Koch Award
Michel C. Nussenzweig, Zanvil A. Cohn and Ralph M. Steinman Professor and head of the Laboratory of Molecular Immunology, has won the 2016 Robert Koch Award. Nussenzweig will share the €100,000 prize, given by the Robert Koch Foundation of Germany, with Alberto Mantovani from Humanitas University...
New mouse models give a boost to the development of cancer immunotherapies
Cancer immunotherapies—drugs that work by making a patient’s immune system better at spotting and destroying tumor cells—are increasingly generating headlines. A number of these drugs are now being used for the treatment of melanoma, lung, and kidney cancers, and are showing promise in clinica...
Researchers find new signs of stress damage in the brain, plus hope for prevention
Chronic stress can make us worn-out, anxious, depressed—in fact, it can change the architecture of the brain. New research at The Rockefeller University shows that when mice experience prolonged stress, structural changes occur within a little-studied region of their amygdala, a part of the brain...
New method gives scientists a better look at how HIV infects and takes over its host cells
Viruses attack cells and commandeer their machinery in a complex and carefully orchestrated invasion. Scientists have long probed this process for insights into biology and disease, but essential details still remain out of reach. A new approach, developed by a team of researchers led by The Rock...
35 labs and counting: How the Robertson Therapeutic Development Fund speeds translational research at Rockefeller
by Alexandra MacWade, assistant editor Developing a new medical product is a complex, high-risk endeavor. Of the thousands of clinically promising concepts scientists formulate each year, only a small fraction move beyond the lab. The Robertson TDF was created to advance work that has gone beyon...
Antibody therapy opens door to potential new treatment for HIV
The development of antiretroviral therapy, a combination of drugs that slows the replication of HIV in the body, has transformed the treatment of this infection. What was once a certain death sentence is now a chronic condition that people can live with for decades. But this therapy has drawbacks...
Charles Rice wins Belgium’s highest scientific prize
Charles M. Rice, Maurice R. and Corinne P. Greenberg Professor in Virology and head of the Laboratory of Virology and Infectious Disease, has been honored with the 2016 InBev-Baillet Latour Health Prize for his work on the hepatitis C virus. Queen Mathilde of Belgium presented Rice with the prize...
An experimental Alzheimer’s drug reverses genetic changes thought to spur the disease
Aging takes its toll on the brain, and the cells of the hippocampus—a brain region with circuitry crucial to learning and memory—are particularly vulnerable to changes that can lead to Alzheimer’s disease or cognitive decline. With the hope of counteracting the changes that can lead to these t...
Drug discovery institute seeks proposals for innovative antibody projects
by Julie Grisham, freelance writer The Tri-Institutional Therapeutics Discovery Institute (Tri-I TDI) has reached a new milestone in its effort to advance the development of new drugs based on basic science discoveries made at Rockefeller and its two neighboring institutions, Weill Cornell M...
In the News - New York Times - Vosshall
Mapping a Genetic Strategy to Fight the Zika Virus "Aware of the new technology, Dr. Vosshall floated the idea of a new Aedes map on Twitter: 'The Aedes aegypti mosquito is infecting millions with #Zika and #Dengue,' she wrote on Jan. 28, 'but we still haven’t put all the pieces of its genome tog...
View
View